Borosil Scientific Limited Announces FY26 Results and Key Leadership Changes
Borosil Scientific Limited announced the consideration and approval of its audited financial results and statements for the year and quarter ended March 31, 2026, following its Board meeting held on May 20, 2026. The company also confirmed the re-appointment of its Chief Executive Officer and detailed key changes in its corporate secretarial leadership.The Board reported that the company’s Statutory Auditor, M/s. Chaturvedi & Shah LLP, has issued the Audit Reports with an unmodified opinion on the audited financial results for both standalone and consolidated entities.
Strategic Developments and Governance Updates
The Board of Directors addressed several key corporate governance points. In terms of personnel, the Board noted the resignation of Mr. Sanjay Gupta as the Company Secretary and Compliance Officer, effective May 20, 2026. This role is set to be filled by Mr. Ramavtar Sharma, who was appointed as the Company Secretary and Compliance Officer and KMP, effective May 21, 2026.Additionally, the Board reviewed the re-appointment of Mr. Vinayak Madhukar Patankar as the Whole-time Director & CEO for a period of three years, effective December 2, 2026.
In a move supporting future growth, the Board also considered seeking shareholder approval by way of an enabling resolution. This resolution aims to authorize the Board to raise funds, as and when required, up to an amount of Rs. 250 crores, using various permissible modes, including qualified institutional placement and further public offering.
Financial Performance Highlights (Year Ended March 31, 2026)
Borosil Scientific Limited presented its audited financial results for the year ended March 31, 2026. The standalone financials showed a profit for the year of 3,972.46 lakhs, while the consolidated results reflected a Total Comprehensive Income of 3,455.12 lakhs for the year.The audited Standalone Financial Results presented include the following comparative data:
| Particulars | Quarter ended (31/03/2026) | Quarter ended (31/12/2025) | Quarter ended (31/03/2025) | Year ended (31/03/2026) | Year ended (31/03/2025) |
|---|---|---|---|---|---|
| Total Income | 13,404.22 | 10,975.55 | 12,034.88 | 43,771.50 | 40,025.01 |
| Total Expenses | 10,519.45 | 9,373.76 | 10,082.64 | 37,544.10 | 35,193.31 |
| Profit/ (Loss) for the Period/Year | 2,153.57 | 1,021.07 | 1,417.41 | 3,972.46 | 3,501.66 |
| Total Comprehensive Income | 2,098.51 | 1,026.88 | 1,436.77 | 3,926.55 | 3,509.37 |
The audited Consolidated Financial Results for the year ending March 31, 2026, show the following:
| Particulars | Quarter ended (31/03/2026) | Quarter ended (31/12/2025) | Quarter ended (31/03/2025) | Year ended (31/03/2026) | Year ended (31/03/2025) |
|---|---|---|---|---|---|
| Total Income | 14,523.14 | 12,371.31 | 13,207.89 | 47,688.74 | 44,630.34 |
| Total Expenses | 11,608.54 | 10,915.22 | 11,805.80 | 42,551.46 | 40,591.22 |
| Profit/ (Loss) for the Period/Year | 2,724.59 | 869.75 | 861.58 | 3,458.12 | 2,672.32 |
Balance Sheet and Cash Flow Summary
The audited Standalone Balance Sheet as of March 31, 2026, reflected total assets of 54,922.61 lakhs and total equity and liabilities of 54,922.61 lakhs.The company's overall financial health was also reviewed via the cash flow statements. The net cash generated from operating activities for the year ended March 31, 2026, stood at 5,045.62 lakhs, marking a decrease from the 12,718.26 lakhs generated in the previous year.
The detailed segment information for the quarter ended March 31, 2026, showed a total revenue from operations of 14,316.87 lakhs, driven primarily by the Scientific - Laboratory Glass & equipment and Process System segment, which contributed 10,960.75 lakhs in revenue.
| Statement | Particulars | Standalone (31/03/2026) (Rs. in lakhs) | Consolidated (31/03/2026) (Rs. in lakhs) |
|---|---|---|---|
| Total Assets | 54,922.61 | 54,908.26 | |
| Total Equity | 46,178.55 | 44,149.26 | |
| Total Liabilities | 8,744.06 | 10,759.00 |
BOROSCI Stock Price Movement
Today, Borosil Scientific Limited shares edged higher, closing at ₹138.00 after gaining 15.60%. The stock posted a strong session, trading on a volume of 336,336 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: